November 2008

Polymed Development nears the end of its first complete year

During the year Polymed has been involved in a wide range of activities covering biotechnology, medical devices, conventional drug development and regulatory affairs.

Projects completed or in progress include designing and setting up a clinical trial of an innovative device for delivering topical oxygen to the surface of non-healing wounds at two major UK teaching hospitals, designing and managing the preclinical programme for a novel anticoagulant molecule, writing a comprehensive development plan for a new intravenous volume expander, designing and supervising the construction of a new environmental allergen exposure chamber now undergoing pilot testing in the USA for the study of ocular and nasal allergy, assisting a UK Government Research Council to write a business plan for a major new biotechnology spin-out company and writing protocols and investigators’ brochures for a number of clinical studies.

We would be pleased to provide you with more details of its services and to discuss ways in which it could assist in your development project whether it is of a conventional small-molecule drug, a biological or a medical device. Whether your products are at a conceptual stage, in clinical or preclinical development or already on the market Polymed is confident that it can provide the expertise and quality that you are looking for